Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The good news is that pharmaceutical manufacturers account for this
Published 2019 Sep 13
Key Benefits Reduces HbA1c and improves blood sugar control Helps with weight loss in overweight/obese patients Convenient weekly dosing reduces treatment burden Cost-effective alternative to branded pens Safety & Usage Guidelines For subcutaneous injection only not IV or IM Inject once weekly in thigh, abdomen, or upper arm Requires regular monitoring of blood glucose, kidney function Use only as prescribed
UPDATE: Not surprisingly, on June 20, 2023, Novo Nordisk announced that it had filed lawsuits for trademark infringement and other claims relating to false advertising by the defendants in those cases
US$ 26.71
/assets/images/provider/photos/2716633.jpg)
US$ 27.84
US$ 21.04
US$ 26.66
US$ 21.31
